(Q39645483)

13 September 2017

title

Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype (English)

1 reference

13 September 2017

0 references

1 reference

acute myeloid leukemia

1 reference

1

1 reference

13 September 2017

I J Falk

2

1 reference

13 September 2017

K Lotfi

3

1 reference

13 September 2017

E Paul

4

1 reference

13 September 2017

M Hermansson

5

1 reference

13 September 2017

R Rosenquist

6

1 reference

13 September 2017

C Paul

7

1 reference

13 September 2017

H Nahi

8

1 reference

13 September 2017

publication date

12 October 2010

1 reference

The Pharmacogenomics Journal

13 September 2017

published in

1 reference

13 September 2017

volume

12

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

111-118

1 reference

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Implications of NRAS mutations in AML: a study of 2502 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Risk assessment in patients with acute myeloid leukemia and a normal karyotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Mechanisms of cancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

P-glycoprotein--a mediator of multidrug resistance in tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Identification of functionally variant MDR1 alleles among European Americans and African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Pharmacogenomics--drug disposition, drug targets, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Predicting drug response and toxicity based on gene polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Pgp and FLT3: identification and modulation of two proteins that lead to chemotherapy resistance in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

mdr-1 single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to paclitaxel chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Intracellular concentrations of mitoxantrone in leukemic cells in vitro vs in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

FLT3 and acute myelogenous leukemia: biology, clinical significance and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Multidrug resistance-1 gene polymorphisms associated with treatment outcomes in de novo acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Multidrug resistance gene G1199A polymorphism alters efflux transport activity of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

A novel MDR1 G1199T variant alters drug resistance and efflux transport activity of P-glycoprotein in recombinant Hek cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Spontaneous reversal of p-glycoprotein expression in multidrug resistant cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

In-vitro transport characteristics discriminate wild-type ABCB1 (MDR1) from ALA893SER and ALA893THR polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FTPJ.2010.79

21 January 2018

Identifiers

DOI

10.1038/TPJ.2010.79

1 reference

Dimensions Publication ID

13 September 2017

1016128500

0 references

1 reference